GREGORY POULIN: Open Payments
NPI 1528077369 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$156 in 6 payments from 4 companies in 2025. Trend: 2023 $96 · 2024 $113 · 2025 $156
Food & beverage: $156
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 2 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Abbott Laboratories | 1 | $21 |
| SCPHARMACEUTICALS INC. | 1 | $16 |
Products named: LIVTENCITY, OPSUMIT, UPTRAVI, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, FUROSCIX.
Industry payments across TX — which companies pay providers there.
